Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

977
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
977
Pneumonia IV: Management01:28

Pneumonia IV: Management

482
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
482
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

377
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
377
Physical Assessment of the Respiratory Tract I: Health History01:28

Physical Assessment of the Respiratory Tract I: Health History

437
Physical assessment of the respiratory tract is critical to patient care. It allows healthcare professionals to identify and manage various respiratory conditions. The process involves a combination of subjective and objective data collection.
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
437
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

509
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
509
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

225
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
225

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of risk factors for hospital-onset bacteremia to inform a routine data based risk prediction - an umbrella review.

The Journal of hospital infection·2026
Same author

Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial.

Intensive care medicine·2026
Same author

Impact of generic market entry on the consumption of last-resort antibiotics in six European countries.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Interhospital Transfers in ICU- and Non-ICU-Treated Sepsis Patients in Germany Between 2016 and 2019.

Critical care explorations·2026
Same author

Microbial cell-free DNA for rapid pathogen identification in clinical diagnostics: a proof of concept study.

Genome medicine·2026
Same author

Real-World Data on the Use of Intravenous Fosfomycin for the Treatment of Central Nervous System Infections: a Subgroup Analysis from the FORTRESS Study.

Infectious diseases and therapy·2026
Same journal

[Outpatient pulmonary rehabilitation].

Der Pneumologe·2022
Same journal

[Parapneumonic pleural effusion in a 37-year-old female patient?]

Der Pneumologe·2022
Same journal

[Development and progress].

Der Pneumologe·2022
Same journal

[Development and progress in mechanical ventilation].

Der Pneumologe·2022
Same journal

[Benefits and risks of treatment with oxygen].

Der Pneumologe·2022
Same journal

[Early pulmonary rehabilitation].

Der Pneumologe·2022
See all related articles

Related Experiment Video

Updated: Oct 2, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.3K

[Development and progress in respiratory tract infections].

Mathias W Pletz1

  • 1Institut für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena/Friedrich Schiller Universität Jena, 07740 Jena, Deutschland.

Der Pneumologe
|February 23, 2022
PubMed
Summary
This summary is machine-generated.

Infectious diseases remain a global threat, necessitating advancements in treating multidrug-resistant pathogens and airway infections. Innovations like pathogen sequencing, AI, and new vaccines are improving patient outcomes and infection management.

Keywords:
COVID-19ImmunomodulationNosocomial pneumoniaResistanceVaccine

More Related Videos

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
06:11

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip

Published on: March 29, 2024

2.0K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

553

Related Experiment Videos

Last Updated: Oct 2, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.3K
Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
06:11

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip

Published on: March 29, 2024

2.0K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

553

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Immunology
  • Vaccinology

Context:

  • Global infectious diseases, including multidrug-resistant pathogens and viral/bacterial airway infections, pose significant threats despite medical advancements.
  • The COVID-19 pandemic highlighted the importance of understanding airway infections and the role of immunomodulation.
  • Carbapenem-resistant Enterobacteriaceae (CRE) present a growing therapeutic challenge in nosocomial pneumonia.

Purpose:

  • To provide an overview of recent significant innovations in the field of airway infections.
  • To highlight advancements in diagnostics, therapeutics, and preventative strategies for managing infectious diseases.

Summary:

  • Recent innovations include pathogen sequencing, point-of-care testing, and artificial intelligence for improved airway infection management.
  • New beta-lactam antibiotics effective against CRE offer therapeutic options, though resistance mechanisms impact efficacy.
  • Vaccine advancements include an extended 20-valent pneumococcal conjugate vaccine for adults and a high-dose influenza vaccine for older adults.

Impact:

  • These innovations are expected to enhance the diagnosis, treatment, and prevention of airway infections and other infectious diseases.
  • Improved management strategies will help combat the threat of multidrug-resistant pathogens and reduce the burden of nosocomial infections.
  • Advances in vaccines and therapeutics contribute to better public health outcomes and preparedness for future infectious disease outbreaks.